This site is for informational purposes only and does not provide medical advice, diagnosis, or treatment. Always consult your healthcare provider.
A Study of Sequential Therapy With AHB-137 Injection Followed by TVAX-008 Injection in Participants Living With Chronic Hepatitis B (CHB) | MicrobiomeTrials
← Back to trials NCT07897448
A Study of Sequential Therapy With AHB-137 Injection Followed by TVAX-008 Injection in Participants Living With Chronic Hepatitis B (CHB) Recruiting PHASE1, PHASE2 INTERVENTIONAL
Read the full scientific description See full eligibility requirements Trial Details Start: 2026-10-31Est. Completion: 2028-09-22
Enrollment target: 105 participantsOther microbiome trials you might be interested in Digital Health Maternal Health Services Prenatal Care Intensive Care, Neonatal Postnatal Care
DED 2.0 is a stepped-wedge cluster-randomized trial testing whether an integrated digital health ecosystem (KuApps, a se…
Mataram, Indonesia Est. completion May 2027
Adrenal Insufficiency
An appropriate hypothalamic-pituitary-adrenal (HPA) axis response is required to survive critical illness. Primary adren…
Bethesda, United States